Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H2MO
|
|||
Former ID |
DNAP001385
|
|||
Drug Name |
Colforsin daropate hci
|
|||
Synonyms |
Adehl (TN); Adele (TN)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Approved | [1] | |
Company |
Nippon Kayaku
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H44ClNO8
|
|||
Canonical SMILES |
CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)OC(=O)CCN(C)C.Cl
|
|||
InChI |
1S/C27H43NO8.ClH/c1-10-24(5)15-18(31)27(33)25(6)17(30)11-13-23(3,4)21(25)20(35-19(32)12-14-28(8)9)22(34-16(2)29)26(27,7)36-24;/h10,17,20-22,30,33H,1,11-15H2,2-9H3;1H/t17-,20-,21-,22-,24-,25-,26+,27-;/m0./s1
|
|||
InChIKey |
VIRRLEDAYYYTOD-YHEOSNBFSA-N
|
|||
CAS Number |
CAS 138605-00-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:31429
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathelicidin antimicrobial peptide (CAMP) | Target Info | Modulator | [2], [3] |
KEGG Pathway | Salivary secretion | |||
Tuberculosis | ||||
Reactome | ROS production in response to bacteria | |||
WikiPathways | Vitamin D Receptor Pathway | |||
Latent infection of Homo sapiens with Mycobacterium tuberculosis | ||||
Integrated Pancreatic Cancer Pathway | ||||
SREBP signalling |
References | Top | |||
---|---|---|---|---|
REF 1 | Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine. Circ J. 2002 Dec;66(12):1150-4. | |||
REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
REF 3 | Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep. 2005 Apr;22(2):162-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.